What the analyst said
Barclays analyst Tom O’Malley raised the price target on Arm Holdings (NASDAQ: ARM) to $200.00 (from $165.00) while maintaining an Overweight rating.
“The Arm Everywhere event made it clear that CPUs play a very important role in agentic AI (napkin math + Jensenomics gets you closer to 1 CPU per 1.4 GPU from something closer to 1 to 2).
ARM’s solution is the AGI CPU, which maximizes performance/watt and plays to ARM’s strength in energy efficiency. Guides to $1B of CPU revenue in FY28 but total revenue of $7.8B (vs.
Street $7.25B) implying Street a bit too heavy on Licensing/Royalty today but in the end a material raise.
We feel comfortable with the $1B as using 30M cores per GW (ARM expects to reach 120M eventually), 19 incremental GW in 2027 (see here), 136 cores in the AGI CPU, and assuming a $1,500 ASP (mgmt ests. ~$1-2K) implies a ~$6.3B AGI CPU opportunity in 2027 – using ARM’s current share of Server units (~15%) implies nearly $1B of revenue.
We would expect more customer announcements / product launches (e.g., XPUs) to drive upside through the end of the decade as well.
We think this is an interesting product that nicely suits the company’s core strength in low power at a time when software hurdles in porting are moving materially lower with LLMs.
We raise our PT to $200 from $165 and maintain our OW rating.”
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
ARM trades at $202. The 2 analysts who set a target in the last 3 months range from $320 to $641, with a median of $481. This $200 target is 58% below the median, the lowest on the Street.
Since the note ARM has moved +50% (from $135). 12-month window: day 223 of 365, closes on March 25, 2027.
Track record
This call✓ Target reached on April 23, 2026, 29 days after the note.
Firm track recordBarclays: 83% of its 40 targets at least a year old were reached within 12 months (#7 of 26 firms). Accuracy ranking →
Barclays on Arm
Barclays price targets on Arm
3 calls from March 25, 2026 to June 1, 2026. The target went from $200 to $360 (+80%). The rating stayed Buy.
- June 1, 2026Target raised from $250 (+44%)Buy$360
- May 8, 2026Target raised from $200 (+25%)Buy$250
- March 25, 2026 This noteEarliest call shownBuy$200




